Ardelyx | ARDX - Current Liabilities

Stock Price
6.12
Daily Change
0.37 6.35%
Monthly
-21.60%
Yearly
19.20%
Q1 Forecast
5.55

Ardelyx reported $83.39M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Ardelyx USD 83.39M 1.67M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
Corcept Therapeutics USD 172.26M 27.6M Sep/2025
Curis USD 19.37M 745K Jun/2025
Sanofi EUR 28.35B 9.32B Dec/2025
TG Therapeutics USD 156.81M 15.08M Sep/2025
United Therapeutics USD 546.3M 19.2M Sep/2025
Xoma USD 28.3M 6.81M Sep/2025